Risk Prediction in Type II Diabetics With Ischemic Heart Disease

NCT01422057 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2014-02-06

No results posted yet for this study

Summary

The purpose of this study is to test whether cardiac autonomic dysfunction predicts is a prognostic marker in type-2 diabetics with ischemic heart disease

Conditions

  • Type-2 Diabetes Mellitus
  • Ischemic Heart Disease

Sponsors & Collaborators

  • Thebiosignals.com

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2014-01-31
Completion
2016-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01422057 on ClinicalTrials.gov